Gallman Cari bought BMY
August 1, 2025 · Form 4 insider transaction
Gallman Cari bought 1,061 shares of Bristol-Myers Squibb Company at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,061
Price
$0.00
Total value
N/A
InsiderGallman Cari
Role—
SecurityCommon Stock, $0.10 par value
Transaction codeM: Option exercise
Transaction dateAugust 1, 2025
Filing dateAugust 5, 2025
Shares owned after9,383
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These restricted stock units vest in three equal installments beginning on August 1, 2024.